Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | DTYMK | P23919 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CASP6 | P55212 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TPMT | P51580 | 1/20 | 0.44 |
| ▸ | CDK2 | P24941 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3707307 | 0.92 | CA1 (0.49) | CA1CA2DTYMKALDH1A1GPR35 | |
| SCHEMBL9489644 | 0.90 | CA1 (0.50) | CA1CA2DTYMKALDH1A1GPR35 | |
| SCHEMBL9489661 | 0.90 | CA1 (0.50) | CA1CA2DTYMKALDH1A1GPR35 | |
| SCHEMBL2722414 | 0.88 | DTYMK (0.51) | CA1CA2DTYMKALDH1A1GPR35 | |
| SCHEMBL31514660 | 0.86 | GPR35 (0.47) | CA1CA2ALDH1A1GPR35SMN1; SMN2 | |
| SCHEMBL1162089 | 0.83 | LMNA (0.53) | CA1CA2DTYMKALDH1A1GPR35 | |
| SCHEMBL2240139 | 0.83 | TSHR (0.53) | CA1CA2DTYMKALDH1A1GPR35 | |
| SCHEMBL22126666 | 0.83 | CA1 (0.45) | CA1CA2DTYMKALDH1A1GPR35 | |
| SCHEMBL16321653 | 0.83 | CA1 (0.45) | CA1CA2DTYMKALDH1A1GPR35 | |
| SCHEMBL1787500 | 0.83 | ALDH1A1 (0.50) | CA1CA2DTYMKALDH1A1GPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115260478-B | Preparation method and application of high-strength high-toughness polylactic acid copolymer | 绍兴文理学院 | 2024-02-02 | — | — | CN | claimed |
| CN-114292305-A | Pharmaceutical co-crystal of progesterone and formic acid derivative and application thereof | 国家卫生健康委科学技术研究所 | 2022-04-08 | — | — | CN | claimed |
| CN-110396052-A | Synthesis method of 5-amino-2, 4-dihydroxybenzoic acid | UNIV ZHEJIANG TECHNOLOGY | 2019-11-01 | — | — | CN | claimed |
| CN-109608347-A | The preparation method of 5- amino -2,4- dihydroxy-benzoic acid | 上海博栋化学科技有限公司 | 2019-04-12 | — | — | CN | claimed |
| CN-115260478-B | Preparation method and application of high-strength high-toughness polylactic acid copolymer | 绍兴文理学院 | 2024-02-02 | — | — | CN | disclosed |
| WO-2023287241-A1 | NOVEL BENZOXAZOLAMINE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING SAME | 주식회사 휴사이온 | 2023-01-19 | — | — | WO | disclosed |
| CN-115260478-A | Preparation method and application of high-strength high-toughness polylactic acid copolymer | 绍兴文理学院 | 2022-11-01 | — | — | CN | disclosed |
| CN-114292305-A | Pharmaceutical co-crystal of progesterone and formic acid derivative and application thereof | 国家卫生健康委科学技术研究所 | 2022-04-08 | — | — | CN | disclosed |
| CN-114292305-A | Pharmaceutical co-crystal of progesterone and formic acid derivative and application thereof | 国家卫生健康委科学技术研究所 | 2022-04-08 | — | — | CN | disclosed |
| CN-110396052-A | Synthesis method of 5-amino-2, 4-dihydroxybenzoic acid | UNIV ZHEJIANG TECHNOLOGY | 2019-11-01 | — | — | CN | disclosed |
| CN-110396052-A | Synthesis method of 5-amino-2, 4-dihydroxybenzoic acid | UNIV ZHEJIANG TECHNOLOGY | 2019-11-01 | — | — | CN | disclosed |
| CN-109608347-A | The preparation method of 5- amino -2,4- dihydroxy-benzoic acid | 上海博栋化学科技有限公司 | 2019-04-12 | — | — | CN | disclosed |
| EP-1963292-B1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2012-02-22 | — | — | EP | disclosed |
| US-7700633-B2 | Organic compounds | NOVARTIS AG (CH) | 2010-04-20 | — | — | US | disclosed |
| CN-101326173-A | Thiadiazoles derivant as anti-diabetes agent | NOVARTIS AG (CH) | 2008-12-17 | — | — | CN | disclosed |
| US-20080262050-A1 | Organic Compounds | NOVARTIS AG (CH) | 2008-10-23 | — | — | US | disclosed |
| EP-1963292-A2 | ORGANIC COMPOUNDS | Novartis Pharma AG (CH) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007067615-A2 | THIADIAZOLE DERIVATIVES AS ANTIDIABETIC AGENTS | NOVARTIS AG (CH) | 2007-06-14 | — | — | WO | disclosed |
| US-6495680-B1 | A HELICAL COMPOSITION COMPRISING A PLURALITY OF AROMATIC SUBSTITUENTS LINKED BY AT LEAST ONE AMIDE GROUP, THE COMPOSITION HAVING A CURVED BACKBONE DUE AT LEAST IN PART TO INTRAMOLECULAR HYDROGEN BONDS THAT RIGIDIFY THE AMIDE LINKAGE | THE UNIVERSITY OF TOLEDO | 2002-12-17 | — | — | US | disclosed |
| US-5201945-A | Mixture of water soluble polysaccharide and organic acid | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1993-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262050-A1 | Organic Compounds | PTPRS, PTPRO, PTPRC | CA1 3771/4885CA2 1607/4885DTYMK 1467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.